Snus is a moist, ground tobacco product that you place under your upper lip instead of smoking. It originated in Sweden, where it has been used for over two centuries, and it delivers nicotine through the gum tissue rather than through the lungs. Unlike cigarettes, snus produces no smoke and requires no spitting, which has made it a subject of ongoing debate about where it fits on the spectrum of tobacco harm.
What’s Inside a Snus Pouch
At its simplest, snus is air-cured tobacco mixed with salt and water. Over time, manufacturers added humectants to keep it moist, flavorings for taste, and alkaline agents like sodium carbonate and sodium bicarbonate to adjust the pH. That pH adjustment isn’t just about flavor. A higher pH converts more of the nicotine into a form that passes through the soft tissue of your mouth more easily, which makes the product more potent and more addictive.
Snus comes in two main forms. Loose snus is a moist, pinchable tobacco you shape with your fingers and pack under your lip. Portioned snus comes pre-packed in small pouches, similar to a tiny tea bag, in mini, slim, and regular sizes. The portioned format is far more popular today because it’s cleaner and more convenient.
How You Use It
You tuck a pouch (or a pinch of loose snus) between your upper lip and gum. It should sit snugly enough to stay in place without pressing uncomfortably against the gum line. Most people keep a pouch in for about 30 to 60 minutes. If you’ve never tried it before, starting with 10 to 15 minutes lets your mouth adjust to the tingling sensation and the nicotine hit before working up to longer sessions.
There’s no need to spit. The moisture in snus releases slowly, and the small amount of liquid produced is generally swallowed. This is one of the reasons snus is considered more discreet than American dipping tobacco, which typically generates enough saliva that users need to spit.
How Nicotine Gets Into Your System
Nicotine from snus absorbs through the lining of your mouth and enters the bloodstream more slowly than nicotine from a cigarette. A cigarette delivers peak nicotine levels in about 7 minutes. Snus and similar oral nicotine products take roughly 60 to 65 minutes to reach their peak. The total amount of nicotine absorbed, however, can be comparable to or even greater than a cigarette, depending on the product’s strength and how long you keep it in. In one study, a 10 mg nicotine pouch delivered significantly more total nicotine over six hours than a single cigarette.
This slower delivery curve means snus doesn’t produce the same sharp spike that makes cigarettes so immediately reinforcing. But the sustained absorption keeps nicotine levels elevated for longer, which is why many users find it satisfying as a replacement for smoking.
Snus vs. Nicotine Pouches
A growing category of products called nicotine pouches (brands like Zyn and Velo) look almost identical to snus but contain no tobacco at all. Instead of ground tobacco leaves, they use plant-based fibers infused with extracted nicotine. This is the key distinction: traditional snus contains actual tobacco, while nicotine pouches are tobacco-free.
The practical differences are subtle but noticeable. Snus pouches tend to be moister and feel slightly fuller in the mouth. They release nicotine more gradually over a longer period. Nicotine pouches are generally drier, produce less saliva, and often deliver a faster initial burst of nicotine. Both come in similar sizes and a wide range of flavors and strengths. In everyday conversation, people sometimes call nicotine pouches “snus,” but they are technically different products, and this distinction matters for both regulation and health risk.
Cancer Risk Compared to Other Tobacco
The cancer profile of snus is notably different from both cigarettes and other forms of smokeless tobacco. A systematic review of studies across multiple regions found that chewing tobacco products showed significantly elevated risk for oral and esophageal cancers, with odds ratios as high as 27.4 for oral cancer. Snus did not show the same pattern. Two European studies evaluating oral cancer risk in snus users found no increased risk, and a third found no increased risk of esophageal cancer.
Pancreatic cancer is the exception. Two cohort studies from Europe reported a significant positive association between snus use and pancreatic cancer, with odds ratios between 1.6 and 2.1, meaning snus users were roughly 60 to 110 percent more likely to develop pancreatic cancer than non-users.
One reason snus appears less harmful than other smokeless tobacco is its lower levels of cancer-causing compounds called tobacco-specific nitrosamines. Swedish snus contains about 3.1 parts per million of these compounds on average. Traditional American dipping tobacco products like Copenhagen and Kodiak average around 7.4 ppm, more than double. Some newer American snus brands test even lower, around 2 ppm.
Cardiovascular Effects
Nicotine, regardless of how it enters the body, triggers the release of stress hormones that raise blood pressure and heart rate. In a controlled study, using a single snus pouch raised systolic blood pressure by about 6 to 8 mmHg and diastolic pressure by about 5 to 6 mmHg within five minutes. Heart rate increased as well, particularly in women, whose average heart rate jumped nearly 12 beats per minute during exposure compared to about 4 beats per minute in men.
Over the long term, snus use has been linked to heart failure, type 2 diabetes, and higher mortality rates after heart attacks and strokes. One finding stands out: people who quit snus after a heart attack cut their mortality risk by nearly 50 percent. These cardiovascular effects are driven largely by nicotine itself, which means they apply in some form to any nicotine product, though the absence of smoke and carbon monoxide removes some of the additional cardiovascular burden that cigarettes carry.
Legal Status Around the World
Snus occupies an unusual regulatory position. It has been banned in the United Kingdom and throughout the European Union since 1992, with Sweden as the sole exception. Sweden negotiated an exemption when it joined the EU in 1995, making it the only EU member state where snus can be legally sold. In the United States, snus is legal but subject to FDA tobacco regulations.
In 2019, the FDA took an unusual step by authorizing one brand, General Snus, to be marketed as a “modified risk tobacco product.” This allows the company to state that using General Snus instead of cigarettes puts you at lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis. That authorization was renewed in November 2024 and extends through 2032. It applies only to that specific brand and does not mean the FDA considers snus safe, only that the evidence supports it being less harmful than cigarettes.
The Bottom Line on Harm
Snus is not a harmless product. It delivers addictive nicotine, raises blood pressure and heart rate, and carries a measurable increase in pancreatic cancer risk. But the evidence consistently places it well below cigarettes in overall harm. It produces no combustion byproducts, contains lower levels of carcinogens than most smokeless tobacco, and has not been clearly linked to oral or lung cancer. For someone who already smokes, switching to snus reduces exposure to the most dangerous components of tobacco use. For someone who doesn’t use nicotine at all, starting snus still means taking on cardiovascular strain and addiction risk that wouldn’t otherwise exist.